{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:32:09Z","timestamp":1757619129781,"version":"3.44.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-025-03534-3","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T04:03:49Z","timestamp":1752638629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of antiangiogenic and immunotherapeutic regimens in the treatment of metastatic pulmonary lymphoepithelioma-like carcinoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Fu-Lian","family":"Qu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Hong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Zhen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jing","family":"Tie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"3","key":"3534_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"10299","key":"3534_CR2","first-page":"535","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, et al. Lung cancer Lancet. 2021;398(10299):535\u201354.","journal-title":"Lung cancer Lancet"},{"issue":"8","key":"3534_CR3","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/cncr.35128","volume":"130","author":"TB Kratzer","year":"2024","unstructured":"Kratzer TB, Bandi P, Freedman ND, et al. Lung cancer statistics, 2023. Cancer. 2024;130(8):1330\u201348.","journal-title":"Cancer"},{"issue":"10","key":"3534_CR4","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/CAD.0000000000001118","volume":"32","author":"A Rizzo","year":"2021","unstructured":"Rizzo A, Dall\u2019Olio FG, Altimari A, et al. Role of PD-L1 assessment in advanced NSCLC: does it still matter? Anticancer Drugs. 2021;32(10):1084\u20135.","journal-title":"Anticancer Drugs"},{"issue":"12","key":"3534_CR5","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.annonc.2024.10.006","volume":"35","author":"ML Meyer","year":"2024","unstructured":"Meyer ML, Peters S, Mok TS, et al. Lung cancer research and treatment: global perspectives and strategic calls to action. Ann Oncol. 2024;35(12):1088\u2013104.","journal-title":"Ann Oncol"},{"issue":"12","key":"3534_CR6","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1080\/17425255.2021.2029405","volume":"17","author":"A Rizzo","year":"2021","unstructured":"Rizzo A, Santoni M, Mollica V, et al. Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study. Expert Opin Drug Metab Toxicol. 2021;17(12):1455\u201366.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"9","key":"3534_CR7","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.molmed.2024.05.009","volume":"30","author":"MA Molina","year":"2024","unstructured":"Molina MA, Steenbergen RDM, Pumpe A, et al. HPV integration and cervical cancer: a failed evolutionary viral trait. Trends Mol Med. 2024;30(9):890\u2013902.","journal-title":"Trends Mol Med"},{"issue":"3","key":"3534_CR8","doi-asserted-by":"publisher","first-page":"e2537","DOI":"10.1002\/rmv.2537","volume":"34","author":"J Wolf","year":"2024","unstructured":"Wolf J, Kist LF, Pereira SB, et al. Human papillomavirus infection: epidemiology, biology, host interactions, cancer development, prevention, and therapeutics. Rev Med Virol. 2024;34(3):e2537.","journal-title":"Rev Med Virol"},{"issue":"2","key":"3534_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2013.07.030","volume":"345","author":"SA Read","year":"2014","unstructured":"Read SA, Douglas MW. Virus induced inflammation and cancer development. Cancer Lett. 2014;345(2):174\u20138.","journal-title":"Cancer Lett"},{"issue":"4","key":"3534_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/jso.2930360413","volume":"36","author":"LR B\u00e9gin","year":"1987","unstructured":"B\u00e9gin LR, Eskandari J, Joncas J, et al. Epstein-Barr virus related lymphoepithelioma-like carcinoma of lung. J Surg Oncol. 1987;36(4):280\u20133.","journal-title":"J Surg Oncol"},{"issue":"5","key":"3534_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1440-1843.2006.00910.x","volume":"11","author":"JC Ho","year":"2006","unstructured":"Ho JC, Wong MP, Lam WK. Lymphoepithelioma-like carcinoma of the lung. Respirology. 2006;11(5):539\u201345.","journal-title":"Respirology"},{"issue":"1","key":"3534_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.21037\/jtd.2017.01.25","volume":"9","author":"CY Lin","year":"2017","unstructured":"Lin CY, Chen YJ, Hsieh MH, et al. Advanced primary pulmonary lymphoepithelioma-like carcinoma: clinical manifestations, treatment, and outcome. J Thorac Dis. 2017;9(1):123\u20138.","journal-title":"J Thorac Dis"},{"issue":"8","key":"3534_CR13","doi-asserted-by":"publisher","first-page":"153043","DOI":"10.1016\/j.prp.2020.153043","volume":"216","author":"Q Wu","year":"2020","unstructured":"Wu Q, Wang W, Zhou P, et al. Primary pulmonary lymphoepithelioma-like carcinoma is characterized by high PD-L1 expression, but low tumor mutation burden. Pathol Res Pract. 2020;216(8):153043.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"3534_CR14","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41379-019-0391-9","volume":"33","author":"Z Xie","year":"2020","unstructured":"Xie Z, Liu L, Lin X, et al. A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung. Mod Pathol. 2020;33(4):626\u201338.","journal-title":"Mod Pathol"},{"issue":"3","key":"3534_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","volume":"17","author":"AG Nicholson","year":"2022","unstructured":"Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17(3):362\u201387.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3534_CR16","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1038\/s41467-019-10902-w","volume":"10","author":"S Hong","year":"2019","unstructured":"Hong S, Liu D, Luo S, et al. The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma. Nat Commun. 2019;10(1):3108.","journal-title":"Nat Commun"},{"issue":"1","key":"3534_CR17","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12890-022-02097-6","volume":"22","author":"M Chen","year":"2022","unstructured":"Chen M, Chen Y, Fang X, et al. Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study. BMC Pulm Med. 2022;22(1):360.","journal-title":"BMC Pulm Med"},{"key":"3534_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/atm.ATM_304_17","volume":"13","author":"CK Tay","year":"2018","unstructured":"Tay CK, Chua YC, Takano A, et al. Primary pulmonary lymphoepithelioma-like carcinoma in Singapore. Ann Thorac Med. 2018;13:30\u20135.","journal-title":"Ann Thorac Med"},{"key":"3534_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.lungcan.2019.09.007","volume":"137","author":"Z Lin","year":"2019","unstructured":"Lin Z, Fu S, Zhou Y, et al. First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma. Lung Cancer. 2019;137:100\u20137.","journal-title":"Lung Cancer"},{"issue":"11","key":"3534_CR20","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/ijc.34426","volume":"152","author":"LL Pang","year":"2023","unstructured":"Pang LL, Liao J, Huang YH, et al. Exploration of immunotherapy in advanced pulmonary lymphoepithelioma-like carcinoma. Int J Cancer. 2023;152(11):2338\u201350.","journal-title":"Int J Cancer"},{"key":"3534_CR21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2147\/OTT.S290113","volume":"14","author":"Y Fu","year":"2021","unstructured":"Fu Y, Zheng Y, Wang PP, et al. Pulmonary Lymphoepithelioma-Like carcinoma treated with immunotherapy or chemotherapy: A single Institute experience. Onco Targets Ther. 2021;14:1073\u201381.","journal-title":"Onco Targets Ther"},{"key":"3534_CR22","doi-asserted-by":"publisher","first-page":"951817","DOI":"10.3389\/fimmu.2022.951817","volume":"13","author":"YM Zhong","year":"2022","unstructured":"Zhong YM, Yin K, Chen Y, et al. PD-1\/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma. Front Immunol. 2022;13:951817.","journal-title":"Front Immunol"},{"issue":"2","key":"3534_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10456-017-9552-y","volume":"20","author":"RR Ramjiawan","year":"2017","unstructured":"Ramjiawan RR, Griffioen AW, Duda DG. Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy? Angiogenesis. 2017;20(2):185\u2013204.","journal-title":"Angiogenesis"},{"issue":"5","key":"3534_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura D, Kloepper J, Amoozgar Z, et al. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol. 2018;15(5):325\u201340.","journal-title":"Nat Rev Clin Oncol"},{"key":"3534_CR25","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.3389\/fimmu.2018.03081","volume":"9","author":"M Georganaki","year":"2018","unstructured":"Georganaki M, van Hooren L, Dimberg A. Vascular targeting to increase the efficiency of immune checkpoint Blockade in Cancer. Front Immunol. 2018;9:3081.","journal-title":"Front Immunol"},{"issue":"6","key":"3534_CR26","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/annonc\/mdy126","volume":"29","author":"H Wang","year":"2018","unstructured":"Wang H, Agulnik J, Kasymjanova G, et al. Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer. Ann Oncol. 2018;29(6):1417\u201322.","journal-title":"Ann Oncol"},{"key":"3534_CR27","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1002\/cncr.27452","volume":"118","author":"Y Liang","year":"2012","unstructured":"Liang Y, Wang L, Zhu Y, et al. Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up. Cancer. 2012;118:4748\u201358.","journal-title":"Cancer"},{"issue":"8","key":"3534_CR28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.5858\/arpa.2018-0149-RS","volume":"143","author":"S Sathirareuangchai","year":"2019","unstructured":"Sathirareuangchai S, Hirata K. Pulmonary lymphoepithelioma-like carcinoma. Arch Pathol Lab Med. 2019;143(8):1027\u201330.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"3534_CR29","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1200\/JCO.21.01845","volume":"40","author":"A Passaro","year":"2022","unstructured":"Passaro A, Brahmer J, Antonia S, et al. Managing resisettance to immune checkpoint inhibitors in lung cancer: treatment and novel strategies. J Clin Oncol. 2022;40(6):598\u2013610.","journal-title":"J Clin Oncol"},{"issue":"21","key":"3534_CR30","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.3390\/cancers16213689","volume":"16","author":"TK Sahin","year":"2024","unstructured":"Sahin TK, Ayasun R, Rizzo A, et al. Prognostic value of Neutrophil-to-Eosinophil ratio (NER) in cancer: A systematic review and Meta-Analysis. Cancers (Basel). 2024;16(21):3689.","journal-title":"Cancers (Basel)"},{"key":"3534_CR31","doi-asserted-by":"publisher","first-page":"1039121","DOI":"10.3389\/fmolb.2022.1039121","volume":"9","author":"DC Guven","year":"2022","unstructured":"Guven DC, Sahin TK, Erul E, et al. The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Front Mol Biosci. 2022;9:1039121.","journal-title":"Front Mol Biosci"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03534-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-025-03534-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03534-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:53:31Z","timestamp":1757246011000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-025-03534-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3534"],"URL":"https:\/\/doi.org\/10.1186\/s13019-025-03534-3","relation":{},"ISSN":["1749-8090"],"issn-type":[{"type":"electronic","value":"1749-8090"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the declaration of Helsinki.This study was conducted with approval from the Ethics Committee of Kai Feng Cental Hospital. The need for informed consent was waived by the ethics committee Review Board of Kai Feng Cental Hospital, because of the retrospective nature of the study. The requirement of patient consent for inclusion was waived. Patient personal privacy and data confidentiality has been upheld.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical registration number"}}],"article-number":"302"}}